- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07733726
Oral Motor and Cognitive Dual-Task Training (OMCDT) Program for Improving Oral and Cognitive Functions Among People With Oral Frailty (OMCDT)
Oral Motor and Cognitive Dual-Task Training (OMCDT) Program for People With Oral Frailty for Improving Oral and Cognitive Functions: a Feasibility Study
The goal of this clinical trial is to proposes a novel Oral Motor and Cognitive Dual-Task Training (OMCDT) program that combines both oral motor exercises and cognitive tasks to improve brain and oral function at the same time. It will also learn about the safety of drug ABC. The main questions it aims to answer is:
Does the OMCDT training can improve the oral and cognitive functions?
Participants will:
Take the OMCDT training once a week for 32 weeks Visit the lab twice in the intervention period (16-week, 32-week) for checkups and tests
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Kowloon, Hong Kong
- The Hong Kong Polytechnic University
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Adults aged 50 years or above;
- Cantonese speaking;
- Having oral frailty, which is defined as having at least two of the following components by Oral Frailty Five-item Checklist (OF-5): (i) Natural teeth fewer than 20, (ii) Have any difficulties eating tough foods now compared with 6 months ago; (iii) Have choked on tea or soup recently; (iv) Often experience having a dry mouth, and (v) Oral diadochokinetic /ta/ sound <6.0 times/second;
- Having subjective cognitive decline (SCD), which refers to self-reported experience of worsening or more frequent confusion or memory loss in the past 12 month, or having been diagnosed with mild or moderate cognitive impairment; defined as a score of 0.5, 1, or 2 on Clinical Dementia Rating (C.D.R) scale;
- Living independently or with partial assistance, defined as a score of Modified Barthel Index score greater than 60 out of 100;
- Right-handed person to minimize variability in cortical activation patterns during fNIRS measurement;
- Can understand the purpose and contents of this project and could give written consent.
Exclusion Criteria:
- Have attended the dental clinics for dental treatment or received orofacial myofunctional therapy (OMT), involving doing certain oral exercises with cheeks, tongue, or lips in previous 6 months;
- Have received other cognitive training in previous 6 month;
- Have impaired vision or hearing capacity that cannot understand the training instructions;
- Have a diagnosis of a neurological or psychiatric condition that could affect cognitive function;
- Have terminal illness, Temporomandibular joint dysfunction (TMJ) disorders; Sjogren's (SHOW-grins) syndrome;
- Have undergone glossectomy surgery;
- have been taking drugs that affect cognitive function (e.g. Benzodiazepines, antidepressants, central nervous drugs).
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Oral Motor and Cognitive Dual-Task Training (OMCDT) intervention group
The participants will be instructed to relax as much as possible, and the surrounding environment will be set up as monotonous as possible.
Only one PC, one (NIRS) with its accessories will be placed on a table.
Particularly, at Week 1, Week 16 and Week 32, participants will be instructed to sit in a comfortable chair in front of the PC and wear the NIRS device.
The intervention will be carried out follow the modified OCMDT protocol.
Each weekly session includes 28 small training activities lasting about 40 min for 32 weeks.
|
Oral Motor and Cognitive Dual-Task Training (OMCDT) program that combines both oral motor exercises and cognitive tasks to improve brain and oral function at the same time, where the training includes 4 types of combined oral and cognitive functions.
|
|
Ingen inngripen: Control Group
The participants in the control group will receive usual care
|
|
|
Eksperimentell: Oral motor exercise group
Participants in the oral motor exercise group will receive evidence-based oral motor exercises without cognitive training.
The intervention will include four components: tongue-lip coordination exercises, tongue muscle strengthening exercises, lip and cheek muscle strengthening exercises, and mastication exercises.
Each component will be repeated for seven rounds, with a 10-second rest interval between rounds.
The intervention will be delivered once per week.
|
The intervention will include four components: tongue-lip coordination exercises, tongue muscle strengthening exercises, lip and cheek muscle strengthening exercises, and mastication exercises.
Each component will be repeated for seven rounds, with a 10-second rest interval between rounds.
The intervention will be delivered once per week.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of participant randomized divided by proportion of people eligible
Tidsramme: Week 16; Week-32
|
Recruitment rate will be assessed by calculating the proportion of participant randomized divided by proportion of people eligible.
|
Week 16; Week-32
|
|
Number of participants that withdraw divided by number of participants randomized
Tidsramme: 16-week; 32-week
|
Attrition rate will be assessed by calculating the number of participants that withdraw divided by number of participants randomized
|
16-week; 32-week
|
|
Proportion of participants who complete the allocated intervention with a minimum of 80% attendance
Tidsramme: 16-week; 32-week
|
Intervention completion rate will be assessed by calculating the proportion of participants who complete the allocated intervention with a minimum of 80% attendance.
|
16-week; 32-week
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Maximum tongue pressure
Tidsramme: Baseline, 16-week, 32-week
|
The tongue pressure will be measured three times using a tongue pressure meter (JMS Co., Ltd., Hiroshima, Japan) and the maximum value will be recorded.
|
Baseline, 16-week, 32-week
|
|
Oral motor coordination
Tidsramme: baseline; 16-week; 32-week
|
Cantonese-specific ODK test will be assessed by counting the number of monosyllabic, disyllabic, and trisyllabic Cantonese syllables (e.g., /bo1/, /bui1 dip6/, /bei2 daan6 gou1/) that the subject can speak out correctly over 5-second interval.
|
baseline; 16-week; 32-week
|
|
Masticatory ability
Tidsramme: baseline; 16-week; 32-week
|
Masticatory ability will be evaluated using xylitol chewing check gum (Lotte, Tokyo, Japan).
Participants will be instructed to chew the xylitol chewing check gum for 60 seconds.
After chewing, place the gum on white paper and compare against a standardized color scale.
|
baseline; 16-week; 32-week
|
|
Self-reported oral health
Tidsramme: Baseline, 16-week, 32-week
|
The self-reported oral health will be evaluated by General Oral Health Assessment Index (GOHAI).
the Chinese version of GOHAI include 12 items There are five response categories for each question (l=always, 2=often,3=sometimes,4=seldom,and 5=never).
The GOHAI score was computed by adding up the scores of the responses to the 12 questions and a higher score indicates a better reported oral health status.
|
Baseline, 16-week, 32-week
|
|
Global cognitive status
Tidsramme: Baseline, 16-week, 32-week
|
The total score of Hong Kong Version of Montreal Cognitive Assessment (HK-MoCA)
|
Baseline, 16-week, 32-week
|
|
Executive function
Tidsramme: baseline; 16-week; 32-week
|
The time in second used by completing the Trail Making Test Part A (TMT-A) and Part B (TMT-B)
|
baseline; 16-week; 32-week
|
|
Memory
Tidsramme: baseline; 16-week; 32-week
|
The score of Fuld Object Memory Evaluation and Modified Verbal Fluency Test (F.O.M.E.
& M.V.F.T.).
|
baseline; 16-week; 32-week
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- P0058617 (Annet stipend/finansieringsnummer: Start-up Fund for RAPs under the Strategic Hiring Scheme)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .